March 2016

Read more about Universal flu vaccine comes a step closer

In a major advance towards a universal flu jab which would protect people against all strains of the virus, researchers have developed a new vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Read more about New nanodrug tracks cancer treatment effectiveness in real time

Using a nanoparticle that delivers a drug and then glows green when cancer cells begin dying, Indian origin researchers have found a way to detect the effectiveness of cancer treatment much sooner than currently available clinical methods.

Sun Pharma acquired established prescription brands from Novartis AG and Novartis Pharma AG (together Novartis) in Japan. In a USD 293 million cash deal Indias Sun Pharmaceutical Industries Ltd. has agreed to buy 14 established prescription brands from Novartis AG and Novartis Pharma AG in Japan, the Indian company said.

In a statement issued late Tuesday the company said that a wholly-owned subsidiary of Sun Pharma will acquire the portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of USD 293 million.

"These brands have combined annualised revenues of approximately USD 160 million and address medical conditions across several therapeutic areas," the company said.

"Under the terms of the agreements, Novartis will continue to distribute these brands, for a certain period, pending transfer of all marketing authorisations to Sun Pharma's subsidiary."

The acquired brands will be marketed by a reliable and established local marketing partner under the Sun Pharma label. The partner will also be responsible for distribution of the brands.

Commenting on the acquisition, Dilip Shanghvi, Managing Director, Sun Pharma said, “Japan is a market of strategic interest for us. This acquisition marks Sun Pharma’s foray into the Japanese prescription market and provides us an opportunity to build a larger product portfolio in the future.”

As per the December-2015 IMS Data, the size of the Japanese pharmaceutical market was estimated at USD 73 billion, accounting for over seven percent of the USD 1 trillion global pharmaceutical market.

<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>

Read more about Indian Society of Nano Medicine to revolutionise country's healthcare system

In an effort to slash high costs, provide customised treatment and improve diagnostic tests, doctors, engineers and researchers from several premiere institutions in the country have created a common platform to intensify research on nanotechnology a promising method for precise treatment.

Read more about Will focus on devolution under health mission: Minister

The government will focus on devolution, decentralisation and timely responsiveness to expand the reach and effectiveness of health programmes under the National Health Mission (NHM), union Health Minister Jagat Prakash Nadda said on Tuesday.

Read more about WHO wants South East Asia to be more wary of diabetes

The World Health Organization (WHO) on Tuesday urged the Southeast Asian countries to promote educational campaigns regarding self-management of diabetes and make its treatment cost effective.

30 March 2016

RECENT INDUSTRIAL DEVELOPMENT IN ORAL THIN FILM TECHNOLOGY: AN OVERVIEW

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Kh. Hussan Reza ¹*, Pranabesh Chakraborty²
¹Department of Pharmacy, Bengal School of Technology, Sugandha, Hooghly, West Bengal
² Director, Department of Pharmacy, Bengal School of Technology, Sugandha, Hooghly, West Bengal
*hassan23pharma@gmail.com

ABSTRACT
Oral route of administration is most convenient route but often is disadvantageous for administering to geriatric and paediatric patients. Orally disintegrating film is found to be effective in delivering rapid drug action by dissolving the drug in buccal cavity. Since a decade oral thin films has got commercial importance in generic and non generic market projecting it as a multinational business asset. Current research in this field is found to be associated with industrialization and commercialization. Current article make an overview of not only technological changes in research and manufacturing but also gives an insight about growing market worldwide.

29 March 2016

Recruitment in research for M.Pharm/M.Sc (6 posts) at Defence Research Laboratory - Govt Job - salary Rs. 25,000 | freshers may apply

Defence Research Laboratory (DRL), Tezpur, under the aegis of Defence Research and development Organisation (DRDO) is engaged in R & D work in the field of management of vectors and vector-borne diseases, biodegradation of organic waste, biotechnology, water quality improvement and utilization of natural resources of northeast India. DRL is equipped with state-of-the-art infrastructure facilities for undertaking pioneering research with defence applications. It provides with excellent environment, motivation and personality development prospects for the talented students, dreaming of unparalleled success in their professional endeavors.

Director, Defence Research Laboratory (DRL), Tezpur (Assam), invites interested and deserving candidates for Walk-in-interview to be held for five posts of Junior Research Fellow and one post of Research Associate having the following basic Qualifications.

Post: Junior Research Fellow, Research Associate

29 March 2016

PHARMA JOB FEST 2016 Organized by School of Pharmacy, Lloyd Institute of Management & Technology

School of Pharmacy at Lloyd Institute of Management & Technology, established in 2004, is a center of excellence for pharmaceutical education. The B.Pharmacy & M.Pharmacy courses are approved by Pharmacy Council of India (PCI) & AICTE. Our Institute is affiliated to Dr. A P J Abdul Kalam Technical University, Lucknow UP (Formerly U P Technical University).

The first ever MEGA PHARMA JOB FEST 2016, is being organized by School of Pharmacy, Lloyd Institute of Management & Technology ,Greater Noida UP, on Saturday, April 9th 2016 at Lloyd Campus.

29 March 2016

Application are invited for Ph.D positions (16 positions) at CiM-IMPRS, Germany

The program is now open for new applications. We offer 16 PhD positions in Life and Natural Sciences. More PhD positions financed by work contracts may be offered depending on availability.

Applications can only be sent via our online system. The system is available during the above mentioned application period only. The deadline for applications is 1 May 2016. References should be uploaded until 3 May 2016. Additions/corrections (see below) can be submitted until late September. The time between selection for interviews and the interview symposium is rather short (for organisational reasons). If you need a passport to travel to Germany and you don't have it yet please already arrange for getting one or make sure that obtaining passport and visa can be done between 10 May and 30 June 2016. Please inspect the webpage of your German embassy.